A new postdoctoral position is available immediately in the laboratory of Dr. Shajila Siricilla at Vanderbilt University Medical Center.
The Siricilla laboratory is focused on identifying novel therapeutic agents to manage infection-induced preterm birth and protecting the fetus against in-utero inflammation. The approaches include a large-scale screening of a customized library of molecules targeting the druggable transcriptome associated with infection-induced inflammation leading to preterm birth. The studies utilize pharmacological and immunological assays, and our laboratory is equipped for high-throughput screening of molecules using an ex vivo fetal membrane explant-based assay, high-throughput combination synergy screening assay and pre-clinical in vivo testing in mouse models of preterm labor. Our laboratory uses human fetal membrane samples and mouse models of preterm labor.
Candidates should have a recent Ph.D. degree with a strong background in pharmacology or immunology and a strong publication record. Individuals with experience in high-throughput screening, in vivo pharmacokinetics and pharmacodynamics, infectious diseases or reproductive biology will be given preference. We value self-motivated, enthusiastic and collaborative team members. Interested individuals should submit a single pdf including: cover letter containing a summary of their prior work and a short paragraph of research interests along with a CV with information for 3 references to [email protected].